Sitemap > Clinical Trials > Infectious Diseases
Displaying 1 - 50 of 445 results
- PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)
- Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
- The Influence of Lopinavir/Ritonavir on Gemfibrozil Pharmacokinetics in Healthy Volunteers
- Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children.
- Vicriviroc To Be Studied In Combination With An Optimized Antiretroviral Regimen Offered To HIV-Treatment Experienced Subjects (Study P04889)
- Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above
- A Phase I/IIa Multicenter Dose-Escalation Study of Subcutaneous Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Patients With CD4 T-Lymphocyte Counts Between 101-400 Cells/mm(3) and Plasma HIV RNA Less Than 1000 Copies/ml After at Least 12 Months of HAART
- Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
- Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
- IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3.
- Efavirenz-Based Versus Nevirapine-Based Antiretroviral Therapy Among HIV-Infected Patients Receiving Rifampin
- Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
- Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
- A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
- Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
- Efficacy, Safety, Reactogenicity & Immunogenicity of the Human Rotavirus Vaccine (HRV) 444563 in Japanese Infants
- Safety and Effectiveness of Raltegravir (MK-0518) in Treatment-Experienced, HIV Infected Children and Adolescents
- A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Females Aged 15-25 Years.
- A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
- Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
- Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
- Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
- AMICI Study: A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients.
- Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
- Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
- Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
- A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy
- Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age
- A Phase I Open-Label Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for the Influenza Virus H5 Hemagglutinin Protein Administered Intradermally in Healthy Adults
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
- A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082)
- Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children
- Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults
- Immunogenicity and Safety of GSK Biologicals
- Month 30 & 42 Extension Studies of CRD-004 Primary Study
- Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
- Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration
- Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB co-Infected Patients (ANRS 12146)
- MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
- A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
- Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
- A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus
- Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
- Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
- Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
- A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
- Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
- Evaluate Safety and Immunogenicity of a Pandemic Influenza Vaccine (GSK1119711A) in Children
- Study Of RV-39 In Patients Who Also Have Asthma